The purpose of the company is the acquisition, holding and exploitation of marketing rights and other rights to products for pharmaceutical human therapies. The company may establish branches in Switzerland and abroad, take over representations and enter into all transactions and conclude contracts that may be suitable to promote the purpose of the company or that are directly or indirectly related to it. It may acquire, hold and sell real estate. The company may provide direct and indirect financing for both direct or indirect subsidiaries and third parties, including its direct or indirect shareholders and their direct or indirect subsidiaries. It may enter into any type of security for the liabilities of such affiliated companies, including pledges on or fiduciary assignments of the company's assets or guarantees of any kind, with or without consideration.